MétaCan
Menu
← Back to cohort
Record W4313561191 · doi:10.21203/rs.3.rs-2386879/v1

Understanding Integrated Hpv Testing and Treatment of Pre- Cancerous Cervical Cancer in Burkina Faso, Cote D’Ivoire, Guatemala and Philippines: Study Protocol

2023· preprint· en· W4313561191 on OpenAlexaff
Mark Kabue, Cindy L. Gauvreau, Nemdia Daceney, Margaret Mary Bertram, Tracey Shissler, Veronica Reis, Mathurin Dodo, Ana Garcés, Cecilia Llave, Blami Dao, Lisa Huang

Bibliographic record

VenueResearch Square · 2023
Typepreprint
Languageen
FieldMedicine
TopicCervical Cancer and HPV Research
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsContext (archaeology)Cervical cancerMedicineThematic analysisDescriptive statisticsObservational studyHealth facilityDeveloping countryData collectionFamily medicineEnvironmental healthSocioeconomicsGeographyPopulationCancerQualitative researchEconomic growthHealth services

Abstract

fetched live from OpenAlex

Abstract Background Many low- and-middle-income countries are disproportionately burdened by cervical cancer, resulting in high morbidity and mortality. HPV-DNA testing couple with treatment with thermal ablation is a recommended screening and precancer treatment strategy, but not enough is known about how this can be effectively implemented in the context of integrated services. The (Scale Up Cervical Cancer Elimination by Secondary prevention Strategy, (SUCCESS) project is conducting a study to understand this approach, integrated into existing women’s health services in Burkina Faso, Cote d’Ivoire, Guatemala, and the Philippines. Methods A hybrid effectiveness-implementation type III mixed-methods observational study design is used to assess feasibility, acceptability, and costs of integrated service delivery in 10 sites per country, selected considering urban/rural location, facility level, onsite/offsite laboratories, and health services type. A combined sample size of about 8,000 women aged 25–49 years was computed, 15% being HIV positive, thus about 2000 per country. The primary outcome is proportion of HPV positive women completing precancer treatment, if eligible, within three months of screening. Data collection and analysis includes; facility and client exit surveys, key informant and client interviews, registries and project records extractions, and costing data analysis. Analysis includes descriptive statistics, context description, thematic analysis, and document analysis. Quantitative analyses will be stratified by participant’s HIV status. Discussion Recruitment is ongoing; started in April 2022 (Burkina Faso and Côte d’Ivoire) and August 2022 (Guatemala and the Philippines). Follow-up of study participants 12-months post-treatment is expected to be completed for all countries by April 2024. In LMICs, integrating cervical cancer secondary prevention services into other health services will likely require specific rather than incidental recruitment of women for screening. Reconfiguration of laboratory infrastructure and planning for sample management must be made well in advance to meet induced demand for screening. Registration: ClinicalTrials.Gov ID: NCT05133661 (24/11/2021)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.026
metaresearch head score (Gemma)0.018
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.029
Threshold uncertainty score0.136

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0260.018
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0030.003
Science and technology studies0.0050.002
Scholarly communication0.0030.002
Open science0.0030.003
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0290.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.379
GPT teacher head0.508
Teacher spread0.128 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicCervical Cancer and HPV Research→French-language works237,207→